UPDATED Mar 30, 2024
Large companies with earnings growth of more than 25% over the past year
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
D05 | S$36.03 | 0.6% | 9.2% | S$93.2b | S$37.47 | PB1.5x | E0.6% | 6.0% | Banks | ||
O39 | S$13.49 | -0.8% | 9.1% | S$60.6b | S$14.43 | PB1.1x | E1.4% | 6.2% | Banks | ||
U11 | S$29.31 | 0.8% | -1.5% | S$49.1b | S$32.49 | PB1.1x | E3.3% | 5.8% | Banks | ||
C38U | S$1.98 | 0.5% | 0% | S$13.3b | S$2.18 | PB0.9x | E-0.5% | 5.4% | Real Estate | ||
U96 | S$5.40 | 2.3% | 23.3% | S$9.6b | S$6.79 | PE9.4x | E-1.7% | 3.0% | Utilities | ||
G07 | S$18.22 | -0.5% | 4.1% | S$8.6b | n/a | PE11.1x | n/a | 4.1% | Insurance | ||
U14 | S$5.75 | -1.0% | -17.0% | S$4.9b | S$7.74 | PE6.9x | E-30.3% | 3.5% | Real Estate Management and Development | ||
H02 | S$9.68 | 1.6% | -0.6% | S$2.1b | n/a | PE9.9x | n/a | 4.1% | Pharmaceuticals & Biotech | ||
BSL | S$1.04 | 0% | -30.2% | S$1.9b | S$1.14 | PE13.4x | E-13.7% | 3.7% | Healthcare | ||
F99 | S$1.04 | 0% | -3.7% | S$1.5b | n/a | PE10.2x | n/a | 5.3% | Food, Beverage & Tobacco |